Dyslipidemia Management in Patients with Coronary Artery Disease. Data from the POLASPIRE Survey

Area of Science:

• Cardiology
• Public Health
• Pharmacology

Background:

• Lipid-lowering therapy significantly reduces cardiovascular event risk in patients with coronary artery disease (CAD).
• Hypercholesterolemia management is critical for patients with established CAD, particularly after acute coronary events or revascularization.

Purpose of the Study:

• To evaluate factors associated with hypercholesterolemia management in patients with established CAD.
• To identify predictors of statin prescription at discharge and lipid-lowering drug (LLD) use and LDL cholesterol goal achievement post-discharge.

Main Methods:

• A study interviewed patients 6-18 months post-hospitalization for acute coronary syndrome (ACS) or myocardial revascularization.
• Data collected included statin prescription at discharge, post-discharge therapy intensity, and factors influencing LLD use and LDL cholesterol control.

Main Results:

• Statin prescription at discharge was high (94.4%), influenced by hospitalization in teaching hospitals, percutaneous coronary intervention, cholesterol measurement, and male sex.
• Post-discharge LLD use was linked to discharge prescription and cardiologist consultation.
• Achieving LDL cholesterol goals was associated with patient-related factors including age, loneliness, professional activity, and diabetes.

Conclusions:

• Health system factors significantly influence lipid-lowering drug utilization in CAD patients post-hospitalization.
• Patient-related factors are more strongly associated with achieving cholesterol control in the long term following CAD events.